About: BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incorporated in 2020 and is based in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $16.61 (-3.93%)
BLSM NASDAQ BlossomHill Therapeutics, Inc. Common Stock
BlossomHill Therapeutics, Inc. Common Stock share price
BLSM price activity
Último preço
$ 16,610
Variação (24h)
-0,68 USD (-3,93%)
Volume
251.28K
Volume (média 4 sem.)
-
Abertura
$ 17,17
Variação do dia
$ 16,12 - $ 17,67
Fechamento anterior
$ 17,29
Último negócio
07 Oct, 8:00 pm GMT+0
Atrasado
07 Oct, 8:00 pm GMT+0
BLSM price performance
Atrasado
07 Oct, 8:00 pm GMT+0
quote.marketSignals